Author Guidelines
Antiviral Therapy is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents, and the treatment of all viral diseases.
Our journal publishes original articles, reviews, editorials, correspondence, short communications and case reports. All manuscripts are submitted through our online ScholarOne Manuscripts™ portal and undergo a thorough peer-review, headed by a team of expert Section Editors
To facilitate the peer-review process and ensure a timely decision, Antiviral Therapy requests that authors are familiar with our Author Guidelines before submitting.
In addition to our Author Guidelines, Antiviral Therapy encourages authors to adhere to the guidelines on good publication practice from the Committee on Publication Ethics (COPE).
Antiviral Therapy
Guidelines for preparation of manuscripts
EDITORIAL POLICY
Antiviral Therapy welcomes the submission of high-quality research on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases.
Manuscripts submitted to Antiviral Therapy are considered for publication on the understanding that the work contained therein has not been submitted simultaneously to another journal. Copies of related manuscripts submitted elsewhere or in press should accompany the submitted manuscript.
All submissions must be accompanied by a covering letter (a letter template is also available on the online submission website), signed by all the authors (or the corresponding author on behalf of all authors) stating that all authors have contributed to the paper, are familiar with the contents of the final draft and agree to be accountable for all aspects of the work, and that all authors meet the criteria for authorship as established by the International Committee of Medical Journal Editors. The letter should also state whether any author has any conflict of interest.
You must declare sources of funding, any influence the funding source may have had on the analyses and reporting of the results and any related interests in the Acknowledgements section of your manuscript. All disclosures and declarations must also be summarized in the manuscript itself. Illustrations and other material obtained from other sources must be acknowledged and it is the author’s responsibility to obtain permission for reproduction/adaptation from the publisher(s). Copies of permission letters/e-mails must be provided to the Editorial Office upon request for all accepted articles.
All manuscripts should be submitted via the online ScholarOne Manuscripts site. Manuscripts will not be accepted via e-mail or post.
Papers will be peer-reviewed and assessed statistically before acceptance. Priority and time of publication of accepted material will be decided by the Section Editors. The Editors retain the right to modify material accepted for publication. This can include subediting the text for style. The Editors endorse the code of conduct and best practice guidelines from the Committee on Publication Ethics (COPE) and GPP3.
Ethics
Papers based on clinical investigation must conform to ethical standards as set out in the Declaration of Helsinki. Reports describing data obtained from experiments performed on animals must clearly indicate that humane standards were adhered to.
For experiments on isolated tissues, the paper must indicate precisely how the donor tissue was obtained. The NIH Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publications) gives guidelines for the acquisition and care of animals.
Randomized controlled trials
Authors are requested to report randomized controlled trials in accordance with the CONSORT (Consolidated Standards of Reporting Trials) statement. This ensures that enough information is provided for Editors, peer-reviewers and readers to see how the study was performed and to judge whether the findings are likely to be reliable. For behavioural and public health evaluations involving non-randomized designs, authors should include with their submission a complete checklist from the TREND statement.
Observational studies
Observational studies (cohort, case-control or cross-sectional designs) should be reported according to the STROBE recommendations.
Systematic reviews
Authors are requested to report these in accordance with the PRISMA statement and the Cochrane Collaboration guidelines. When conducting any literature review, it is important that there is complete transparency concerning the choice of material included. All systematic reviews must therefore contain a brief section entitled Search strategy and selection criteria. This should state clearly the sources (databases, journals or book reference lists, etc.) of the material covered and the criteria used to include or exclude studies. Systematic reviews should fit the submission category of Original article as outlined below.
Retractions and Expressions of concern
The journal will follow COPE guidelines on handling Retractions and Expressions of concern.
An article may be retracted under the following circumstances:
• the materials have been published previously without correct cross-referencing in place, permission or justification
• there is clear evidence that the findings are unreliable either due to misconduct or honest error
• plagiarism
• reports unethical research
An Expression of concern may be published under the following circumstances:
• inconclusive evidence of research or publication misconduct by the authors
• evidence that the findings are unreliable but the authors’ institution will not investigate the case
• an investigation is underway but a decision cannot be reached for a considerable time
SUBMISSION CATEGORIES
All manuscripts submitted to Antiviral Therapy must contain a disclosure statement.
Review
3,000–5,000 words, ≤100 references, ≤5 display items
Reviews include definitive overviews of a major topic or updates of knowledge in a somewhat narrower field of current interest. References cited in the article should be chosen for their importance, ease of access, and for the ‘further reading’ opportunities they provide.
All reviews should be prefaced by a summary of 100–120 words that contains sufficient information for the reader to be able to appreciate the relevance of the full article when read alone. Summaries are used by abstracting services and many users of these services read only the summary. It should include background information and specific examples of recent advances. References should not be included and abbreviations should be avoided as far as possible in the summary.
Original article
≤4,000 words, ≤50 references, ≤5 display items
Original articles include any novel research, encompassing randomized and non-randomized trials, observational studies (e.g., cohort, case-control and cross-sectional studies) and systematic reviews.
Original articles are prefaced by a structured abstract (maximum 250 words) that includes the following sections: ‘Background’, ‘Methods’, ‘Results’ and ‘Conclusions’. The main body of text should include the following sections: ‘Introduction’, ‘Methods’, ‘Results’ and ‘Discussion’.
Systematic reviews should be identified as ‘systematic review’ or ‘meta-analysis’, as appropriate, within the title (see Systematic reviews, above).
Short communication
≤1,500 words, ≤20 references, ≤3 display items
Original research findings that do not require a full paper, but are completed studies, may be submitted as a short communication.
All short communications should follow the format of an original article and should be prefaced by a structured abstract under the headings: ‘Background’, ‘Methods’, ‘Results’ and ‘Conclusions’ (maximum 250 words). The main body of text should include the following sections: ‘Introduction’, ‘Methods’, ‘Results’ and ‘Discussion’.
……
更多详情：
https://www.intmedpress.com/?pid=53
